IMV Phase 2 clinical results with Merck Keytruda in DLBCL - ICML Update
If you have previously registered for this event, please login below:

Email		LOGIN


Registration is required to attend this event. Please register now.
First Name*

Last Name*

Company*

Email*

Business Phone*


You must have Javascript and Cookies enabled to access this webcast. Click here for Help.

Please enable Cookies in your browser before registering for the webcast.
*Denotes required.

REGISTER

Speakers

Fred Ors, President and CEO
Pierre Labbe, Vice-President and CFO
Gabriela Rosu, MD, Chief Medical Officer
Stephan Fiset, Vice-President Clinical Research
Marianne Stanford, Ph.D., Vice-President, Research and Development